Literature DB >> 26019202

Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997.

Michael Z David1, Mary Ellen Acree2, Julia J Sieth2, Dave J Boxrud3, Ginette Dobbins3, Ruth Lynfield3, Susan Boyle-Vavra2, Robert S Daum2.   

Abstract

Widespread infections with community-associated (CA) methicillin-resistant Staphylococcus aureus (MRSA) have occurred in the United States with the dissemination of the USA300 strain beginning in 2000. We examined 105 isolates obtained from children treated at the University of Chicago from 1994 to 1997 (75 methicillin-susceptible S. aureus [MSSA] and 30 MRSA isolates) in order to investigate for possible evidence of USA300 during this period. Infections were defined epidemiologically based on medical record review. The isolates underwent multilocus sequence typing (MLST), as well as assays for the Panton-Valentine leukocidin (PVL) genes, the protein A gene (spa), and arcA and opp3, proxy markers for the arginine catabolic mobile element (ACME), characteristic of USA300 MRSA. MRSA isolates also underwent staphylococcal cassette chromosome mec (SCCmec) typing and pulsed-field gel electrophoresis (PFGE) subtyping. MSSA isolates belonged to 17 sequence type (ST) groups. The 12 epidemiologically defined CA-MRSA infection isolates were either ST1 (n = 4) or ST8 (n = 8). They belonged to 3 different PFGE types: USA100 (n = 1), USA400 (n = 5), and USA500 (n = 6). Among the CA-MRSA infection isolates, 8 (67%) were PVL(+). None of the MRSA or MSSA isolates contained arcA or opp3. Only one MRSA isolate was USA300 by PFGE. This was a health care-associated (HA) MRSA isolate, negative for PVL, that carried SCCmec type II. USA300 with its characteristic features was not identified in the collection from the years 1994 to 1997.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26019202      PMCID: PMC4508449          DOI: 10.1128/JCM.00096-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  48 in total

1.  Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails.

Authors:  Erica S Pan; Binh A Diep; Heather A Carleton; Edwin D Charlebois; George F Sensabaugh; Barbara L Haller; Françoise Perdreau-Remington
Journal:  Clin Infect Dis       Date:  2003-10-17       Impact factor: 9.079

2.  Assessment of allelic variation in the ccrAB locus in methicillin-resistant Staphylococcus aureus clones.

Authors:  Duarte C Oliveira; Catarina Milheiriço; Susana Vinga; Hermínia de Lencastre
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

Review 3.  Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Steven R Gill; Richard F Chang; Tiffany HaiVan Phan; Jason H Chen; Matthew G Davidson; Felice Lin; Jessica Lin; Heather A Carleton; Emmanuel F Mongodin; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

4.  Evolving epidemiology of pediatric Staphylococcus aureus cutaneous infections in a Baltimore hospital.

Authors:  Aaron E Chen; Mitchell Goldstein; Karen Carroll; Xiaoyan Song; Trish M Perl; George K Siberry
Journal:  Pediatr Emerg Care       Date:  2006-10       Impact factor: 1.454

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

6.  Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV.

Authors:  Susan Boyle-Vavra; Ben Ereshefsky; Chih-Chien Wang; Robert S Daum
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children.

Authors:  Kristina G Hultén; Sheldon L Kaplan; Blanca E Gonzalez; Wendy A Hammerman; Linda B Lamberth; James Versalovic; Edward O Mason
Journal:  Pediatr Infect Dis J       Date:  2006-04       Impact factor: 2.129

8.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

9.  Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children's Hospital.

Authors:  Steven C Buckingham; Linda K McDougal; Lorene D Cathey; Katha Comeaux; Allen S Craig; Scott K Fridkin; Fred C Tenover
Journal:  Pediatr Infect Dis J       Date:  2004-07       Impact factor: 2.129

10.  Community-associated methicillin-resistant Staphylococcus aureus in pediatric patients.

Authors:  Theresa J Ochoa; John Mohr; Audrey Wanger; James R Murphy; Gloria P Heresi
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

View more
  8 in total

Review 1.  Life After USA300: The Rise and Fall of a Superbug.

Authors:  Paul J Planet
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

2.  Carriage of Methicillin-resistant Staphylococcus aureus in a Colony of Rhesus (Macaca mulatta) and Cynomolgus (Macaca fascicularis) Macaques.

Authors:  Abigail W Greenstein; Susan Boyle-Vavra; Carol W Maddox; Xiwei Tang; Lisa C Halliday; Jeffrey D Fortman
Journal:  Comp Med       Date:  2019-08-02       Impact factor: 0.982

3.  Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel.

Authors:  E Berla-Kerzhner; A Biber; M Parizade; D Taran; G Rahav; G Regev-Yochay; D Glikman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-27       Impact factor: 3.267

Review 4.  Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis.

Authors:  Catherine Dunyach-Remy; Christelle Ngba Essebe; Albert Sotto; Jean-Philippe Lavigne
Journal:  Toxins (Basel)       Date:  2016-07-07       Impact factor: 4.546

5.  Pan-genomic perspective on the evolution of the Staphylococcus aureus USA300 epidemic.

Authors:  Dorota M Jamrozy; Simon R Harris; Naglaa Mohamed; Sharon J Peacock; Charles Y Tan; Julian Parkhill; Annaliesa S Anderson; Matthew T G Holden
Journal:  Microb Genom       Date:  2016-05-31

6.  Molecular Characteristics of Community-Associated Staphylococcus aureus Isolates From Pediatric Patients With Bloodstream Infections Between 2012 and 2017 in Shanghai, China.

Authors:  Xing Wang; Qian Liu; He Zhang; Xia Li; Weichun Huang; Qihua Fu; Min Li
Journal:  Front Microbiol       Date:  2018-06-06       Impact factor: 5.640

7.  USA300 Staphylococcus aureus persists on multiple body sites following an infection.

Authors:  Timothy D Read; Robert A Petit; Zachary Yin; Tuyaa Montgomery; Moira C McNulty; Michael Z David
Journal:  BMC Microbiol       Date:  2018-12-05       Impact factor: 4.465

8.  Clinical and molecular epidemiology of invasive Staphylococcus aureus infection in Utah children; continued dominance of MSSA over MRSA.

Authors:  Hillary Crandall; Aurélie Kapusta; Jarrett Killpack; Carly Heyrend; Kody Nilsson; Mandy Dickey; Judy A Daly; Krow Ampofo; Andrew T Pavia; Matthew A Mulvey; Mark Yandell; Kristina G Hulten; Anne J Blaschke
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.